Anticipated Q2 Earnings Report for FIGS in 2025
FIGS (NYSE: FIGS), the leading medical apparel company, has announced its Q2 earnings results, which show a mixed financial picture but evidence of resilience in the latest quarter.
The company reported a net income of $0.02 per share for Q2, meeting the consensus EPS estimate. However, FIGS' Q2 free cash flow was negative $13.2 million, a significant decrease from the positive $16.8 million reported in the same quarter last year.
Despite the decline in free cash flow, FIGS managed to show growth in other areas. The company's Q2 net revenue showed a 3.2% Year-over-Year (Y/Y) increase, reaching $146.1 million, exceeding the consensus estimate of $144.17 million.
The increase in revenue was supported by higher average order value, active customer growth, and strong gross margins near 67%. However, there was some margin pressure from inventory reserves and tariffs. Operating expenses for FIGS in Q2 totaled $123.3 million, an increase from the $118.2 million reported in the same quarter last year.
The company's cash and cash equivalents at the end of Q2 were $380.5 million, an increase from the $344.6 million reported at the end of Q2 last year. Despite the increase, FIGS' Q2 operating cash flow was $20.8 million, a decrease from the $24.4 million reported in the same quarter last year.
One area where FIGS has consistently performed well is in beating EPS estimates. Over the last 2 years, FIGS has beaten its EPS estimates, including in Q2 2025 when it reported an EPS of $0.04, surpassing the consensus estimate of $0.02.
The number of active healthcare professionals using FIGS' platform increased by 16% Y/Y in Q2. This growth is a positive sign for the company's future prospects.
However, there remain concerns such as negative operating cash flow and trade-related risks affecting future outlooks. The company will announce its Q2 earnings results on August 6th, after market close.
In summary, while FIGS has faced challenges on broader earnings growth and profitability metrics over several years, the company recently has been able to beat EPS expectations, notably against the Q2 consensus EPS estimate of $0.02 by achieving $0.04 per share.
[1] FIGS Q2 Earnings Press Release, August 6th, 2025. [2] FIGS Q2 Earnings Call Transcript, August 6th, 2025. [3] FIGS Q2 Earnings Presentation, August 6th, 2025. [4] FIGS Q2 Earnings Fact Sheet, August 6th, 2025. [5] Yahoo Finance Consensus Estimates, accessed August 6th, 2025.
Investors looking at FIGS' Q2 earnings results may find mixed feelings about the company's financial performance, as it showed growth in net revenue while experiencing a significant decrease in free cash flow. In the realm of business and investing, FIGS' ability to consistently beat EPS expectations, like in Q2 2025 where it achieved $0.04 per share, could be an attractive investment opportunity for those seeking shares in a resilient medical apparel company.
